11-14, 14:35–14:50 (Asia/Bangkok), Breakout 3
Varro has developed a unique semiconductor-based biosensor platform that detects pathogens in human breath and indoor air with significant improvements in speed, sensitivity, and cost over existing technologies. The platform will be offered via open source to expand its reach and accessibility. We will discuss the core technology and how it can be used to prevent the spread of disease and new pandemics around the world.
Dr. Tom Cirrito is a serial entrepreneur, inventor, and founder of multiple biotechnology companies. He is CEO and Chairman of the Board of Varro, and Founder and Executive Chairman of Filament BioSolutions. Dr. Cirrito was previously Managing Partner of Astonishing Labs, a venture creation fund. He began his biotechnology career as Vice President of R&D and Director of Business Development at Stemline Therapeutics (NASDAQ: STML) where he led development of a leukemia drug through FDA approval.